J&J Cost Savings Effort Includes Eliminating Thousands Of Pharma Positions

Johnson & Johnson is eliminating thousands of positions in its pharmaceuticals unit in an effort to achieve pre-tax annual cost savings of $1.3 billion to $1.6 billion, the firm announced July 31